HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Vitiligo

A disorder consisting of areas of macular depigmentation, commonly on extensor aspects of extremities, on the face or neck, and in skin folds. Age of onset is often in young adulthood and the condition tends to progress gradually with lesions enlarging and extending until a quiescent state is reached.
Networked: 2375 relevant articles (236 outcomes, 415 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Psoriasis (Pustulosis Palmaris et Plantaris)
2. Blister (Bulla)
3. Lichen Planus (Lichen Ruber Planus)
4. Atopic Dermatitis (Atopic Eczema)
5. Melanoma (Melanoma, Malignant)

Experts

1. Schallreuter, Karin U: 24 articles (08/2013 - 01/2002)
2. Xu, Aie: 19 articles (12/2015 - 07/2008)
3. Parsad, Davinder: 19 articles (01/2015 - 12/2002)
4. Lotti, Torello: 18 articles (11/2015 - 01/2008)
5. Li, Kai: 16 articles (05/2015 - 03/2009)
6. Gao, Tianwen: 16 articles (01/2015 - 03/2009)
7. Gupta, Somesh: 15 articles (12/2015 - 01/2002)
8. Kanwar, A J: 14 articles (05/2015 - 10/2001)
9. Lim, Henry W: 14 articles (05/2015 - 08/2003)
10. Kemp, E Helen: 14 articles (01/2015 - 04/2002)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Vitiligo:
1. Tacrolimus (Prograf)FDA LinkGeneric
2. calcipotriene (calcipotriol)FDA LinkGeneric
3. Ficusin (Psoralen)IBA
4. pimecrolimus (Elidel)FDA Link
5. Adrenal Cortex Hormones (Corticosteroids)IBA
6. Melanins (Melanin)IBA
7. CalcineurinIBA
8. Phenylalanine (L-Phenylalanine)FDA Link
9. Folic Acid (Vitamin M)FDA LinkGeneric
10. xenon chlorideIBA

Therapies and Procedures

1. Phototherapy (Light Therapy)
2. Excimer Lasers
3. Transplantation (Transplant Recipients)
4. Transplants (Transplant)
5. PUVA Therapy